Healthcare Services

Gene Panel Market Size Outlook and Demand Growth Across 2026–2030

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Gene Panel Market During 2026–2030?

The gene panel market has experienced substantial growth in recent times. Its expansion is projected to continue, reaching $2.85 billion in 2026 from $2.47 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 15.3%. Historically, this growth was driven by factors such as advancements in next-generation sequencing, a decrease in sequencing expenditures, wider adoption of clinical genetics, the proliferation of diagnostic laboratories, and increased oncology biomarker research.

The gene panel market is anticipated to experience substantial expansion in the coming years, projected to reach $4.96 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.9%. This growth throughout the forecast period is attributed to several factors, including the advancement of personalized medicine, the broader availability of hereditary disease testing, the increasing need for precision diagnostics, the incorporation of AI into genomic analysis, and wider clinical acceptance. Furthermore, major trends for this period are expected to include the rising adoption of multi-gene diagnostic panels, their increased application in cancer risk assessment, the expansion of customized gene panel testing, a surging demand for pharmacogenomic insights, and the integration of gene panels into clinical decision-making.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21190&type=smp

Which Economic Or Industry Drivers Are Impacting The Gene Panel Market?

The rising occurrence of cancer is projected to stimulate expansion within the gene panel market in the future. Cancer refers to a collection of illnesses marked by the unregulated proliferation and dissemination of atypical cells, capable of infiltrating and harming adjacent tissues and organs. The incidence of cancer is escalating due to elements like an aging demographic, shifts in lifestyle, exposure to environmental factors, and advancements in detection and diagnostic methods. Gene panels assist in cancer management through facilitating extensive genetic analysis to pinpoint mutations and modifications in particular genes, thereby informing customized treatment plans and enhancing results for individuals with cancer. As an illustration, in January 2023, PubMed, a US-based free search engine for biomedical and life sciences literature maintained by the United States National Library of Medicine, indicated that for 2023, an estimated 1,958,310 new cancer diagnoses and 609,820 cancer fatalities are anticipated in the United States. Consequently, the expanding occurrence of cancer is a key impetus for the development of the gene panel market.

How Are The Various Segments Of The Gene Panel Market Categorized?

The gene panel market covered in this report is segmented –

1) By Product And Services: Test Kits, Testing Services

2) By Technology: Amplicon-Based, Hybridization-Based, Other Technologies

3) By Design: Predesigned Gene Panel, Customized Gene Panel

4) By Application: Cancer Risk Assessment, Diagnosis Of Congenital Diseases, Pharmacogenetics, Other Applications

5) By End-User: Research Institutes, Hospital, Diagnosis Centers, Pharmaceutical Companies, Other End-Users

Subsegments:

1) By Test Kits: Predesigned Gene Panels, Customized Gene Panels

2) By Testing Services: Cancer Risk Assessment Panels, Pharmacogenetic Testing Panels, Neurological Disorder Panels, Cardiovascular Disease Panels, Rare Disease Panels

Which Trends Are Impacting The Growth Of The Gene Panel Market?

Leading companies in the gene panel market are prioritizing the development of innovative technologies, such as oncology panels, to improve the accuracy, efficiency, and thoroughness of cancer diagnostics and individualized treatment approaches. Oncology panels are specialized gene analysis tools that examine multiple genes linked to cancer, identifying genetic mutations and alterations, which assists in the diagnosis, prognosis, and therapeutic management of cancer. For example, in May 2023, Vizgen Inc., a US-based biotechnology company, released the MERFISH PanCancer Pathways Panel, providing a customizable choice for scientists exploring spatial genomics. These predesigned panels are suited for various research purposes, including cancer investigations, and are engineered for enhanced error resilience, delivering dependable and consistent findings. By combining spatial context with gene expression data, the panels provide more profound insights into tumor microenvironments and cellular interactions, thereby facilitating more focused and personalized cancer research and the creation of new treatments. This introduction signifies a major progression in spatial biology, allowing researchers to study intricate biological systems with unparalleled detail.

Which Major Firms Influence Developments In The Gene Panel Market?

Major companies operating in the gene panel market are F. Hoffmann-La Roche, Thermo Fisher Scientific, Quest Diagnostics, Eurofins Scientific, Agilent Technologies, Illumina, Qiagen, Myriad Genetics, Guardant Health, Invitae, Integrated DNA Technologies, Bio-Rad, Novogene, Fulgent Genetics, MedGenome, Centogene, Blueprint Genetics, BIONEER, BGI Group.

Read the full gene panel market report here:

https://www.thebusinessresearchcompany.com/report/gene-panel-global-market-report

What Are The Top-Performing Regions Within The Gene Panel Market?

North America was the largest region in the gene panel market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene panel market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Gene Panel Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21190&type=smp

Browse Through More Reports Similar to the Global Gene Panel Market 2026, By The Business Research Company

Crispr Gene Editing Global Market Report

https://www.thebusinessresearchcompany.com/report/crispr-gene-editing-global-market-report

Genome Editing Or Genome Engineering Global Market Report

https://www.thebusinessresearchcompany.com/report/genome-editing-or-genome-engineering-global-market-report

Genes Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795